
Reset all filters
01 6Enasidenib Mesylate
Reset all filters
01 142806444
02 157551679
03 175226515
04 178791111
05 193705063
06 1118905343.2
Reset all filters
01 12018
02 12019
03 12020
04 12021
05 12022
06 12023
Company : Celgene/BMS
Enasidenib Mesylate
Drug Cost (USD) : 118,905,343
Year : 2023
Prescribers : 813
Prescriptions : 3608
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Celgene/BMS
Enasidenib Mesylate
Drug Cost (USD) : 93,705,063
Year : 2022
Prescribers : 677
Prescriptions : 3031
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Celgene/BMS
Enasidenib Mesylate
Drug Cost (USD) : 78,791,111
Year : 2021
Prescribers : 605
Prescriptions : 2646
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Celgene/BMS
Enasidenib Mesylate
Drug Cost (USD) : 75,226,515
Year : 2020
Prescribers : 608
Prescriptions : 2657
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Celgene
Enasidenib Mesylate
Drug Cost (USD) : 57,551,679
Year : 2019
Prescribers : 506
Prescriptions : 2121
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Celgene
Enasidenib Mesylate
Drug Cost (USD) : 42,806,444
Year : 2018
Prescribers : 456
Prescriptions : 1636
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF